Ivermectin for the prevention of COVID-19: addressing potential bias and medical fraud

Abstract Background Ivermectin is an antiparasitic drug being investigated in clinical trials for the prevention of COVID-19. However, there are concerns about the quality of some of these trials. Objectives To conduct a meta-analysis with randomized controlled trials of ivermectin for the preventio...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of antimicrobial chemotherapy 2022-04, Vol.77 (5), p.1413-1416
Hauptverfasser:	Hill, Andrew, Mirchandani, Manya, Ellis, Leah, Pilkington, Victoria
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiparasitic Agents COVID-19 - drug therapy Editor's Choice Fraud Humans Ivermectin - therapeutic use Original Research Randomized Controlled Trials as Topic Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!